Expertise in
131
conditions

Dr. Naveed Chowhan

Hematology | Oncology
Floyd Memorial Hospital And Health Services
2210 Green Valley Rd, 
New Albany, IN 
Expertise in
131
conditions
Floyd Memorial Hospital And Health Services
2210 Green Valley Rd, 
New Albany, IN 

Overview

Naveed Chowhan is a Hematologist and an Oncologist in New Albany, Indiana. Dr. Chowhan is highly rated in 131 conditions, according to our data. His top areas of expertise are Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, Non-Hodgkin Lymphoma, Congenital Antithrombin 3 Deficiency, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in IN

Hospital Affiliations

Schneck Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Floyd Memorial Hospital and Health Services
2210 Green Valley Rd, New Albany, IN 47150
Other Locations
Schneck Medical Center
411 W Tipton St, Seymour, IN 47274

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

An Open-Label, Randomized, Multicenter Study Evaluating the Activity of Lasofoxifene Relative to Fulvestrant for the Treatment of Pre- and Postmenopausal Women With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
An Open-Label, Randomized, Multicenter Study Evaluating the Activity of Lasofoxifene Relative to Fulvestrant for the Treatment of Pre- and Postmenopausal Women With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Enrollment Status: Completed
Publish Date: January 28, 2026
Intervention Type: Drug
Study Drugs: Lasofoxifene, Fulvestrant
Study Phase: Phase 2
An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients With Locally Advanced or Metastatic Solid Tumors That Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements
An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients With Locally Advanced or Metastatic Solid Tumors That Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements
Enrollment Status: Active_not_recruiting
Publish Date: January 08, 2026
Intervention Type: Drug
Study Drug: Entrectinib
Study Phase: Phase 2
A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)
A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Drug, Other
Study Drug: Ribociclib
Study Phase: Phase 3
A Multicenter, Randomized, Open-label, 3-Arm Phase 3 Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
A Multicenter, Randomized, Open-label, 3-Arm Phase 3 Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Two-part, Open-label, Randomized, Phase 2/3 Study of Dinutuximab and Irinotecan Versus Irinotecan for Second Line Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer
A Two-part, Open-label, Randomized, Phase 2/3 Study of Dinutuximab and Irinotecan Versus Irinotecan for Second Line Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: December 09, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of 0.1% Uracil Topical Cream (UTC) in the Prevention of Hand-Foot Syndrome (HFS) in Patients With Metastatic Breast Cancer Treated With Capecitabine
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of 0.1% Uracil Topical Cream (UTC) in the Prevention of Hand-Foot Syndrome (HFS) in Patients With Metastatic Breast Cancer Treated With Capecitabine
Enrollment Status: Completed
Publish Date: October 08, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 5 Less Clinical Trials

2 Total Publications

Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial.
Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 18, 2020
Similar Doctors
Expertise in
74
conditions
Dr. Michael Kommor
Hematology | Oncology
Expertise in
74
conditions
Dr. Michael Kommor
Hematology | Oncology

Baptist Health Lagrange Kresge Pharmacy

4003 Kresge Way Ste 500, 
Louisville, KY 
 (49.3 miles away)
502-897-1166
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Kommor is a Hematologist and an Oncologist in Louisville, Kentucky. Dr. Kommor is highly rated in 74 conditions, according to our data. His top areas of expertise are Splenic Neoplasm, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Lung Cancer.

Expertise in
18
conditions
Dr. Ashok Raj
Hematology | Oncology
Expertise in
18
conditions
Dr. Ashok Raj
Hematology | Oncology

Norton Children's Sleep Medicine-Novak Center

411 E Chestnut St, 
Louisville, KY 
 (49.5 miles away)
502-588-3600
Languages Spoken:
English
See accepted insurances

Ashok Raj is a Hematologist and an Oncologist in Louisville, Kentucky. Dr. Raj is highly rated in 18 conditions, according to our data. His top areas of expertise are Sickle Cell Disease, Immune Thrombocytopenic Purpura (ITP), Hemoglobin SC Disease, Bone Marrow Aspiration, and Lithotripsy.

Expertise in
55
conditions
Dr. Udaya Joseph
Hematology | Oncology
Expertise in
55
conditions
Dr. Udaya Joseph
Hematology | Oncology

Baptist Health Lagrange Kresge Pharmacy

4003 Kresge Way Ste 500, 
Louisville, KY 
 (49.3 miles away)
502-897-1166
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Udaya Joseph is a Hematologist and an Oncologist in Louisville, Kentucky. Dr. Joseph is highly rated in 55 conditions, according to our data. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Myelodysplastic Syndrome (MDS), and Inflammatory Breast Cancer.

Frequently Asked Questions about Dr. Naveed Chowhan

How do I make an appointment with Dr. Naveed Chowhan?

You can book an appointment with Dr. Naveed Chowhan by calling their office at 812-284-4771. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Naveed Chowhan a top-rated expert for Hemangioma Thrombocytopenia Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Naveed Chowhan is classified as an Distinguished expert for Hemangioma Thrombocytopenia Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Naveed Chowhan specialize in?

While Dr. Naveed Chowhan is a Hematology, they have specific expertise in Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, and Non-Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Naveed Chowhan participate in research or clinical trials?

Yes. Dr. Naveed Chowhan has published 2 articles and abstracts on conditions like Hemangioma Thrombocytopenia Syndrome. You can view a list of Dr. Naveed Chowhan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Naveed Chowhan accept my insurance?

Dr. Naveed Chowhan accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 812-284-4771 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chowhan's expertise for a condition
ConditionClose
    View All 49 Distinguished Conditions
    View All 82 Advanced Conditions
    View All 160 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile